Table 2. Factors associated with effect of conservative treatment (n=151).
| Characteristics | Total | CR | p-value | Treatment duration (mo) | p-value | |
|---|---|---|---|---|---|---|
| Total | 151 | 141 (93.4) | - | - | - | |
| Age at diagnosis (yr) | <30 | 46 | 44 (95.7) | 0.720 | 7.0±0.6 | 0.620 |
| ≥30 | 105 | 97 (92.4) | - | 6.8±0.4 | - | |
| BMI (kg/m2) | <25.0 | 84 | 82 (97.6) | 0.023 | 6.3±0.4 | 0.019 |
| ≥25.0 | 67 | 59 (88.1) | - | 7.6±0.5 | - | |
| IR | No | 90 | 86 (95.6) | 0.320 | 6.1±0.4 | 0.004 |
| Yes | 61 | 55 (90.2) | - | 8.1±0.5 | - | |
| MS | No | 91 | 85 (93.4) | 0.620 | 6.5±0.4 | 0.220 |
| Yes | 60 | 56 (93.3) | - | 7.4±0.5 | - | |
| Hypertension | No | 142 | 132 (93.0) | 0.530 | 6.9±0.3 | 0.880 |
| Yes | 9 | 9 (100.0) | - | 7.0±1.6 | - | |
| Diabetes mellitus | No | 146 | 136 (93.2) | 1.000 | 6.8±0.3 | 0.430 |
| Yes | 5 | 5 (100.0) | - | 8.8±1.8 | - | |
| Nulliparous | Yes | 107 | 103 (96.3) | 0.064 | 6.9±0.4 | 0.660 |
| No | 44 | 38 (86.4) | - | 6.7±0.5 | - | |
| Progestin therapy | MA alone | 82 | 78 (95.1) | 0.510 | 6.7±0.4 | 0.650 |
| MA+metformin | 69 | 63 (91.3) | - | 7.1±0.5 | - | |
Data are shown as number (%) or mean ± standard deviation.
BMI, body mass index; CR, complete response; MA, megestrol acetate; MS, metabolic syndrome; IR, insulin resistance.